Isis Pharmaceuticals Inc (NASDAQ:ISIS)

Thursday’s trading has closed, but ISIS is being traded in the after-hours session. After-Hours quote »
66.71
Delayed Data
As of 3:59pm ET
 -1.01 / -1.49%
Today’s Change
26.57
Today|||52-Week Range
77.80
+8.05%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$8.1B

Company Description

Isis Pharmaceuticals, Inc. engages in the development and commercialization of antisense drug discovery platform. It operates through the Drug Discovery and Development segment which exploits a novel drug discovery platform created to generate a broad pipeline of first-in-class drugs for the company and its partners. Its products are used to treat diseases such as severe and rare, cardiovascular, neurologic and metabolic diseases, and cancer. The company was founded by Stanley T. Crooke in January 1989 and is headquartered in Carlsbad, CA.

Contact Information

Isis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad California 92010
P:(760) 931-9200
Investor Relations:
(760) 603-2741

Employees

Shareholders

Individual stakeholders6.92%
Mutual fund holders57.44%
Other institutional29.60%

Top Executives

Stanley T. CrookeChairman, President & Chief Executive Officer
B. Lynne ParshallChief Operating Officer, Secretary & Director
Elizabeth L. HougenChief Financial Officer & SVP-Finance
C. Frank BennettSenior Vice President-Antisense Research
Brett P. MoniaSenior VP-Drug Discovery & Corporate Development

To view my watchlist

Not a member yet?

Sign up now for a free account